Softgel Capsule Market

Softgel capsules which is also known as softgels, are a type of capsule made of a soft, gelatin-based material that envelops a liquid or semi-solid fill. The fill material and gelatin shell offer different advantages over traditional hard capsules. Softgel shells are thinner and more flexible than hard capsules, thereby allowing more fill to be delivered in a smaller dosage form which is appreciated by consumers. The gelatin material also permits faster dissolution of the shell, thus making the fill available for absorption more quickly after ingestion compared to hard capsules.

There are two main types of softgel capsules. The first type is surrounded by a single soft gelatin shell which contains the active fill ingredient. The second type has a dual-layered construction with an inner sealing layer preventing leakage of the fill and an outer support layer providing structural integrity. Softgels are capable of holding liquid, semi-solid and even dry or paste-like fills which opens up formulation possibilities beyond what is offered by hard capsules. However, softgel manufacturing requires specialized equipment and expertise as compared to hard capsules which can increase production costs. Their gelatin-based shell is also less stable than hard capsule shells making them more vulnerable to heat, moisture and improper storage conditions.

Market Dynamics

Global softgel capsule market is mainly driven by the increasing prevalence of cardiovascular diseases across the world, thus leading to increasing consumption and demand of softgel capsules. Various cardiovascular diseases such as atherosclerosis, coronary artery diseases, and others have become major healthcare burdens, especially in developed nations with aging populations and lifestyle changes. As cardiac associations, cardiovascular diseases have emerged as the leading cause of mortality and long-term disabilities. For instance, on May 15, 2023, according to the report published by the Centers for Disease Control and Prevention, heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the U.S., while one person dies every 33 seconds in the U.S. from cardiovascular disease.

Furthermore, in November 2022, according to the report published by the Public Health Agency in Canada, heart disease is the second leading cause of death in Canada, claiming more than 50,000 lives each year.

Key features of the study

• This report provides in-depth analysis of the global softgel capsule market, and provides market size (USD Mn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global softgel capsule market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Catalent, Inc., Aenova Group GmbH, Sirio Pharma Company Ltd, Captek Softgel International Inc., Elnova Pharma, Fuji Capsule Co., Ltd., Capsugel, EuroCaps Ltd, Guangdong Yichao Biological Co., Ltd., Hunan ER-KANG Pharmaceutical Co Ltd, KD Pharma Group, United Laboratories, Soft Gel Technologies, Inc., Windzor Pharma Ltd , ZYUS Life Sciences Inc. and EuroCaps.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global softgel capsule market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global softgel capsule market.

Market Segmentation

• By Product Type
• Gelatin Softgel Capsule
• Non-gelatin Softgel Capsule
• By Source Type
• Animal-based
• Non-animal-based
• By Application
• Anti-inflammatory Drugs
• Antibiotic Drugs
• Cardiovascular Drugs
• Health Supplements
• Others
• By End User
• Pharmaceutical Companies
• Contract Manufacturing Organizations
• Neutraceuticals Companies
• Others
• By Region
• North America
• U.S.
• Canada
• Latin America
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Europe
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• GCC Countries
• Israel
• Rest of Middle East
• Africa
• South Africa
• North Africa
• Central Africa
• Top Companies in Global Softgel Capsule Market
• Catalent, Inc.
• Aenova Group GmbH
• Sirio Pharma Company Ltd.
• Captek Softgel International Inc.
• Elnova Pharma
• Fuji Capsule Co., Ltd.
• Capsugel, EuroCaps Ltd.
• Guangdong Yichao Biological Co., Ltd.
• Hunan ER-KANG Pharmaceutical Co Ltd.
• KD Pharma Group
• United Laboratories
• Soft Gel Technologies, Inc.
• Windzor Pharma Ltd.
• ZYUS Life Sciences Inc.
• EuroCaps

Show more